U. Graeven
Department of Medicine
Ruhr University Bochum (Knappschaftskrankenhaus)
In der Schornau 23-25
Bochum 44892
Germany
Name/email consistency: high
- Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer. Graeven, U., Kremer, B., Südhoff, T., Killing, B., Rojo, F., Weber, D., Tillner, J., Unal, C., Schmiegel, W. Br. J. Cancer (2006)









